Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s

Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests of LX9851 in combination with semaglutide, the main ingredient in Novo Nordisk’s Wegovy. The post Novo Nordisk Lands Lexicon Pharma Obesity…

Read More

Bridging the AI Gap in Local Health: Practical Steps for Adoption

By prioritizing staff education, starting small with practical applications, and establishing clear guidelines, local health departments can lay the foundation for sustainable AI adoption. This approach ultimately enhances efficiency, improves health outcomes, and ensures cost-effective care for the communities they serve. The post Bridging the AI Gap in Local Health: Practical Steps for Adoption appeared…

Read More

Sheila O’Donnell to Retire, Leaves Legacy of Key Achievements at HTS

Sheila O’Donnell has been instrumental in Crothall’s Health Technology Systems (HTS) tripling its revenues since 2016. HTS now manages over one million medical devices and clinical technologies in more than 200 U.S. hospitals.  As Senior Vice President of the Technical Resource Group, she oversaw HTS’s operations, including information technology, cybersecurity, supply chain management, technology assessment,…

Read More